Author

K. A. Heck

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

A. J. Patel· 1 shared A. Jalali· 1 shared A. L. Bailey· 1 shared A. L. Bredemeyer· 1 shared A. P. Nair· 1 shared A. S. Rali· 1 shared C. Schmidt· 1 shared C.-Y. Lin· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. J. Patel

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis

A. L. Bailey, O. Dmytrenko, L. Greenberg, A. L. Bredemeyer, P. Ma, J. Liu, V. Penna, L. Lai, E. S. Winkler, S. Sviben, E. Brooks, A. P. Nair, K. A. Heck, A. S. Rali, L. Simpson, , K. J. Lavine

This study shows SARS-CoV-2 infects human engineered heart tissues, causing myocarditis-like features, and identifies ACE2 and proteases as entry factors.

bioRxiv · Nov 4, 2020Immunology

Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors

A. J. Patel, Y.-W. Wan, R. Al-Ouran, J.-P. Revelli, M. F. Cardenas, M. Oneissi, L. Xi, A. Jalali, J. Magnotti, D. M. Muzny, H. Doddapaneni, S. Sebastian, K. A. Heck, J. C. Goodman, S. P. Gopinath, , T. J. Klisch

This study identifies three molecular types of meningiomas that better predict recurrence than WHO grading and links aggressive tumors to loss of DREAM complex repression.

bioRxiv · Sep 10, 2019Cancer Biology